[]화학물질법규소식: 「EU REACH SVHC」 개정

19 Feb 2024
시행일: 2024년 1월 23일 
규제개요
  • REACH(Registration, Evaluation, Authorization and Restriction of Chemicals)는 화학물질 등록, 평가, 허가, 제한 등의 절차를 규정한 통합 관리 제도입니다.

  • SVHC(Substances of Very High Concern)는 고위험성우려물질을 말합니다.

  • SVHC는 REACH Article 59(10)에 의거 Candidate List (후보물질목록)을 통해 고시됩니다.

  • Candidate List에 등재 시 물질 신고, 정보 공유, SCIP 제출 등의 의무 사항이 발생할 수 있습니다.

  • SVHC는 지속적인 평가를 통해 추후 Authorisation List (허가물질목록)에 추가될 수 있습니다.

변경사항 요약
  • 신규 추가: 5건

  • 물질 정보 갱신: 1건

관련 링크
변경사항 세부

추가: 5건

물질명
EC No.
CAS No.
등재 사유

2,4,6-tri-tert-butylphenol 

211-989-5 

732-26-3

Toxic for reproduction

(Article 57c)

Persistent, bioaccumulative and toxic (PBT)

(Article 57d)

2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol

221-573-5

3147-75-9

Very persistent and very bioaccumulative (vPvB)

(Article 57e)

2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one 

438-340-0

119344-86-4

Toxic for reproduction

(Article 57c)

Bumetrizole

223-445-4 

3896-11-5 

vPvB

(Article 57e)

Oligomerisation and alkylation reaction products of 2-phenylpropene and phenol 

700-960-7

-

vPvB

(Article 57e)


물질 정보 갱신: 1건

물질명
EC No.
CAS No.
등재 사유

Dibutyl phthalate (updated entry)

(* Entry란 Candidate List에 등재된 물질 혹은 물질그룹을 말하며, 등재 사유 등에 변경이 있을 시 entry udpate를 진행하게 됩니다)

201-557-4

84-74-2

Toxic for reproduction (Article 57c)

Endocrine disrupting properties (Article 57(f) - human health)

Endocrine disrupting properties (Article 57(f) - environment) 

(* 이번 개정을 통해 추가된 사유)




MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.


MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

MDSKorea Inc.

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office : 173, Digital-ro, Geumcheon-gu, Seoul, Korea 

Incheon Office : 22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

Yongin Office: 338, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea 

Copyright ⓒ 2023 MDSKorea Inc. All Rights Reserved